Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Establishing Feasibility of Transbronchial Cryoablation With an In-Development Cryoprobe: An Ex-Vivo Human Lung Model

NCT: NCT07104253 · NOT_YET_RECRUITING

NCT IDNCT07104253
StatusNOT_YET_RECRUITING
Start Date2026-12
Completion2028-12
SponsorEndocision Technologies Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Demonstrate the application of in-development cryogenic catheters for the ablation of pulmonary lesions.

Frequently Asked Questions

What is Establishing Feasibility of Transbronchial Cryoablation With an In-Development Cryoprobe: An Ex-Vivo Human Lung Model?

Establishing Feasibility of Transbronchial Cryoablation With an In-Development Cryoprobe: An Ex-Vivo Human Lung Model is a clinical trial registered under NCT07104253. Current status: NOT_YET_RECRUITING.

What is the status of NCT07104253?

The current status of NCT07104253 (Establishing Feasibility of Transbronchial Cryoablation With an In-Development Cryoprobe: An Ex-Vivo Human Lung Model) is: NOT_YET_RECRUITING.

When did Establishing Feasibility of Transbronchial Cryoablation With an In-Development Cryoprobe: An Ex-Vivo Human Lung Model start?

Establishing Feasibility of Transbronchial Cryoablation With an In-Development Cryoprobe: An Ex-Vivo Human Lung Model started on 2026-12.

Related Devices

K240776Celsio Flexible Cryocatheter SystemEndocision Technologies, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑